← Back to catalogue

Mobius3D 4.1

EUDAMEDFDA UDIFDA 510(k)

Class IIb (EU MDR)

Ref Mobius3D 4.1

by Varian Medical Systems, Inc.

Identity

Trade Name
Mobius3D EUDAMEDFDA UDI
Generic Name
Radiation therapy software FDA UDI
Device Name
Mobius3D EUDAMED
Model / Reference
Mobius3D 4.1 EUDAMED
4.1 FDA UDI

Identifiers

Primary DI / UDI-DI
00850800006050 EUDAMEDFDA UDI
Basic UDI-DI
089947500200115PM EUDAMED
510(k) Number
K250099 FDA UDI
FDA Product Code
IYE FDA UDI
EMDN Code
Z11010482 RADIOTHERAPY TREATMENT PLANNING INSTRUMENTS - SOFTWARE ACCESSORIES EUDAMED
GMDN Term
Radiation therapy software FDA UDI

Classification

Device Class
Class IIb EUDAMED
Class II FDA UDI
Regulation Number
892.5050 FDA UDI
Special Device Type
Software EUDAMED
Market of Registration
Netherlands EUDAMED
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

No

FDA UDI

Implantable

No

EUDAMEDFDA UDI

Reusable

No

EUDAMED

Contains Latex

No

EUDAMEDFDA UDI

Reprocessed

No

EUDAMED

CMR Substance

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Endocrine Disruptor

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

The Mobius3D 4.1 is a Radiation Therapy Planning System (Nomenclature Code: Z11010482), designed for advanced treatment planning in radiotherapy. It integrates 3D imaging and dose calculation algorithms to optimize patient-specific radiation therapy protocols, supporting complex treatment modalities such as intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT).

Mobius3D 4.1 is supplied as a software application for use on compatible radiotherapy treatment planning workstations, requiring no sterilization or reprocessing. It operates in clinical radiation oncology settings and is classified as a Class IIb medical device under regulatory frameworks, including FDA 510(k) clearance and MDR compliance. The system is non-reusable, non-sterile, and non-implantable, with a unique Device Identifier (DI) code of 00850800006050.

Frequently asked questions

What is the primary purpose of the Mobius3D 4.1 system in a clinical setting?

The Mobius3D 4.1 is designed specifically for advanced radiation therapy planning. It integrates 3D imaging and sophisticated dose calculation algorithms to optimize patient-specific treatment protocols, particularly for complex modalities like intensity-modulated radiation therapy (IMRT) and volumetric modulated arc therapy (VMAT). This ensures precise targeting of radiation while minimizing exposure to healthy tissue.

How is the Mobius3D 4.1 supplied and does it require any special handling?

The Mobius3D 4.1 is supplied as a software application for radiotherapy treatment planning workstations. Since it is non-sterile (sterility status: 0) and non-reusable (reusable status: 0), it does not require sterilization or reprocessing. It is intended for single-use in clinical settings, though the software itself can be installed and utilized repeatedly across multiple patients on compatible hardware.

Is the Mobius3D 4.1 compatible with other medical devices or systems in a radiotherapy workflow?

The Mobius3D 4.1 is a standalone software solution designed to integrate with radiotherapy treatment planning workstations. While the data does not specify direct compatibility with other devices, its role in optimizing IMRT and VMAT suggests it is intended to work within existing radiotherapy workflows that rely on 3D imaging and dose calculation systems. Compatibility would depend on the specific hardware and software infrastructure of the facility.

What regulatory pathways has the Mobius3D 4.1 undergone, and how does this affect its use?

The Mobius3D 4.1 has obtained FDA 510(k) clearance and complies with the EU Medical Device Regulation (MDR). These pathways confirm that the system meets the necessary safety, performance, and quality standards for use in clinical radiation oncology settings. The classification as a Class IIb device further indicates it undergoes rigorous evaluation to ensure its effectiveness and safety in advanced radiotherapy planning.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (2 countries)

Regulatory Authorizations

United States Active

FDA_510K

United States Active

FDA_510K

United States Active

FDA_510K

United States Active

FDA_510K

European Union Active

CE/MDR

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
US-MF-000001784
Authorised Representative
Siemens Healthineers Nederland B.V. NL-AR-000000803

Sources (3)

  • EUDAMED f36b18ac-99f1-4ffb-a2b2-2983419c9f3e 61 fields · synced Sep 18, 2026
  • FDA UDI 9370dbf1-ddf2-400d-b173-258618eb72ed 33 fields · synced May 30, 2026
  • FDA 510(k) K250099 1 fields · synced May 18, 2026